News | June 22, 2022
MedC Biopharma partners with A2W Pharma to develop cannabinoid therapeutics
Bringing next-gen cannabinoid therapeutics to cancer patients
Bringing next-gen cannabinoid therapeutics to cancer patients
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Both manufacturing facilities are based out of Benguluru, India
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development
EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails
Acceptance based on results from the phase 3 KEYNOTE-091 trial
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
Subscribe To Our Newsletter & Stay Updated
